PharmaCyte Biotech Statistics
NASDAQ: PMCBHealthcareBiotechnologyUSD
0.3974-0.0082 (-2.02%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
PharmaCyte Biotech by the numbers
PharmaCyte Biotech has a market capitalization of $4.3 million based on 10.74M shares outstanding. With trailing EPS of $-2.31, PharmaCyte Biotech is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 18.8% below its 50-day average and 41.6% below its 200-day average.
Average daily trading volume is 205.72K shares, or about $81,752 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
PMCB valuation vs. peer median
| Metric | PMCB | Peer median | Difference |
|---|---|---|---|
| Market cap | $4.27M | $3.85M | +11% |
| Avg. volume | 205.72K | 291.79K | -29% |
Peer median across 8 companies: ERNA, PPCB, EOCN, NCNA, CLDI, PCSA, GRI, JUNS.
Valuation
- Market cap
- $4.27M
- EPS (TTM)
- $-2.31
- Shares outstanding
- 10.74M
Price and trading
- Previous close
- 0.4056
- Open
- 0.4073
- Day range
- 0.39 – 0.4219
- 52-week range
- 0.3339 – 1.51
- 50-day moving average
- 0.4891
- Beta
- —
- Volume
- 214.13K
- Average volume
- 205.72K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 11, 2025
Additional statistics
- Market Cap
- 4.27M
- Forward Pe
- -1.05
- Eps
- -2.31
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 1.51
- Week52 Low
- 0.33
- Avg Volume
- 205.72K
- Shares Outstanding
- 10.74M
- Ma50
- 0.49
- Ma200
- 0.68
- Earnings Date
- Aug 11, 2025
- Pct From52w High
- -73.68%
- Pct From52w Low
- 19.02%